首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Comparative Activities of Clinafloxacin Grepafloxacin Levofloxacin Moxifloxacin Ofloxacin Sparfloxacin and Trovafloxacin and Nonquinolones Linozelid Quinupristin-Dalfopristin Gentamicin and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureus Strains
【2h】

Note: Comparative Activities of Clinafloxacin Grepafloxacin Levofloxacin Moxifloxacin Ofloxacin Sparfloxacin and Trovafloxacin and Nonquinolones Linozelid Quinupristin-Dalfopristin Gentamicin and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureus Strains

机译:注意:克林沙星格雷帕沙星左氧氟沙星莫西沙星氧氟沙星司帕沙星和托伐沙星和壬喹诺酮类杀菌剂奎奴普丁-达福普汀庆大霉素和万古霉素对环丙沙星-金葡菌的临床分离物的比较活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The activities of eight fluoroquinolones and linezolid, quinupristin-dalfopristin (Synercid), gentamicin, and vancomycin were tested against 96 ciprofloxacin-susceptible and 205 ciprofloxacin-resistant Staphylococcus aureus strains. Overall, clinafloxacin, followed by moxifloxacin and trovafloxacin, was the most active quinolone tested. For all isolates, linezolid and quinupristin-dalfopristin showed activities that were at least comparable to vancomycin, with no cross-resistance to any other test compound.
机译:测试了八种氟喹诺酮和利奈唑胺,奎奴普丁-达福普汀(Synercid),庆大霉素和万古霉素对96例对环丙沙星敏感和205例对环丙沙星耐药的金黄色葡萄球菌的活性。总体而言,经测试的最活跃的喹诺酮是克林沙星,其次是莫西沙星和曲伐沙星。对于所有分离株,利奈唑胺和奎奴普丁-达福普汀的活性至少与万古霉素相当,与其他任何测试化合物均无交叉耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号